Registry of Toxic Effects of Chemical Substances (RTECS)
Ether, 2,2-dichloro-1,1-difluoroethyl methyl
RTECS #
KN7820000CAS #
76-38-0Updated
April 2012Molecular Weight
164.97Molecular Formula
C3H4Cl2F2OSynonyms
2,2-Dichloro-1,1-difluoroethyl methyl etherAnalgizer
Anecotan
Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-
Ingalan
Inhalan
Methoflurane
Methoxane
Methoxyfluran
Methoxyflurane
Metofane
Metoxfluran
Metoxifluran
NSC-110432
Penthrane
Pentran
Pentrane
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg | moderate | FEPRA7 35,729,1976 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | lymphocyte/human | 200 ppm/24H | ENVRAL 12,366,1976 |
Cytogenetic Analysis | fibroblast/mouse | 100 ppm | ENVRAL 12,366,1976 |
Cytogenetic Analysis | parenteral/chicken | 10 mg | ENVRAL 12,366,1976 |
other mutation test systems | fibroblast/hamster | 1 pph | ANESAV 43,21,1975 |
other mutation test systems | inhalation/rat | 5000 ppm/3H-continuous | EXPEAM 35,71,1979 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | 100 ppm/8H (1-21D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | ANESAV 48,11,1978 |
inhalation/rat | 400 ppm/8H (1-21D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system | ANESAV 48,11,1978 |
inhalation/mouse | 2 ppm/4H (6-15D pregnant) | Reproductive: Specific developmental abnormalities: Urogenital system | AACRAT 59,421,1980 |
inhalation/mouse | 2000 ppm/4H (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Musculoskeletal system | AACRAT 59,421,1980 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/Dog | lowest published toxic concentration: 3 pph | Lung, Thorax, or Respiration: Other changes Liver: Fatty liver degeneration Endocrine: Hyperglycemia | VCVGK* -,286,1994 |
inhalation/human | lowest published toxic concentration: 3500 ppm/1H | Kidney, Ureter, and Bladder: Renal function tests depressed | CANJAE 21,294,1974 |
inhalation/mammal (species unspecified) | lethal concentration (50 percent kill): 34 gm/m3 | Behavioral: Antipsychotic | GTPZAB 24(4),55,1980 |
inhalation/mouse | lethal concentration (50 percent kill): 122600 mg/m3/4H | VCVGK* -,286,1994 | |
inhalation/mouse | lethal concentration (50 percent kill): 21500 mg/m3 | Behavioral: General anesthetic Behavioral: Somnolence (general depressed activity) Behavioral: Excitement | GTPZAB 22(7),55,1978 |
inhalation/rat | lethal concentration (50 percent kill): 33500 mg/m3/4H | 85GMAT -,53,1982 | |
inhalation/rat | lowest published toxic concentration: 0.5 pph/2H | Behavioral: Food intake (animal) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | VCVGK* -,286,1994 |
intravenous/mouse | lethal dose (50 percent kill): 150 mg/kg | USXXAM #4168308 | |
oral/mammal (species unspecified) | lethal dose (50 percent kill): 3600 mg/kg | Behavioral: Antipsychotic | GTPZAB 24(4),55,1980 |
oral/rat | lethal dose (50 percent kill): 3.6 mg/kg | VCVGK* -,286,1994 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/mouse | lowest published toxic concentration: 48600 mg/m3/4H/30D- intermittent | Lung, Thorax, or Respiration: Other changes Liver: Other changes Endocrine: Adrenal cortex hyperplasia | VCVGK* -,286,1994 |
inhalation/rat | lowest published toxic concentration: 1100 mg/m3/60D- intermittent | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Other changes Kidney, Ureter, and Bladder: Other changes | VCVGK* -,286,1994 |
inhalation/rat | lowest published toxic concentration: 50 ppm/24H/14W- continuous | Liver: Changes in liver weight Kidney, Ureter, and Bladder: Other changes in urine composition Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | APTOA6 57,176,1985 |
inhalation/rat | lowest published toxic concentration: 48600 mg/m3/4H/30D- intermittent | Liver: Other changes | FATOAO 35,271,1972 |
Reviews
Organization | Standard | Reference |
---|---|---|
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Inadequate Evidence | IMSUDL 7,93,1987 |
TOXICOLOGY REVIEW | ARPTDI 16,67,1976 | |
TOXICOLOGY REVIEW | KDYIA5 10,82,1976 | |
TOXICOLOGY REVIEW | CANJAE 19,152,1972 | |
TOXICOLOGY REVIEW | ARMCAH 25,411,1974 | |
TOXICOLOGY REVIEW | AACRAT 57,328,1978 | |
TOXICOLOGY REVIEW | TPHSDY 23,519,2002 | |
TOXICOLOGY REVIEW | AINCM* 7,63,2006 | |
TOXICOLOGY REVIEW | DIMON* 39,678,1993 | |
TOXICOLOGY REVIEW | HUTOX* -,577,1996 | |
TOXICOLOGY REVIEW | NBREV* 5,1,1981 |
Standards and Regulations
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO METHOXYFLURANE-air | ceiling concentration 2 ppm | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 82904; Number of Industries 2; Total Number of Facilities 2120; Number of Occupations 14; Total Number of Employees Exposed 32772; Total Number of Female Employees Exposed 18210 | |
National Occupational Hazard Survey 1974 | Hazard Code 82904; Number of Industries 2; Total Number of Facilities 627; Number of Occupations 6; Total Number of Employees Exposed 8095 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division